National CooperativeRx constantly monitors the pharmaceutical pipeline. As treatment options change, it’s important to know how those changes could impact your plan and which drugs bring the highest value. Our quarterly NCRx Pipeline Reports highlight some of the newest therapies coming to market and are not intended to imply formulary placement or coverage by CVS Caremark. Varenicline

The Cooperative’s new Advanced Utilization Management (UM) Program has officially launched! National CooperativeRx constantly monitors the pharmaceutical marketplace for new therapies in the pipeline. We have implemented our opt-in Advanced UM program to offer our member groups an opportunity to employ our recommendations on a quarterly basis to better adapt their plans to the rapidly

Measurement is an action we use in many aspects of our lives. We run three miles. We drink two cups of coffee (and sometimes more!). A workday is eight hours. It is no surprise that as a society and culture we are reflecting, and measuring, our lives since the World Health Organization (WHO) declared the

Ensure Proper Rebate Benefits for Your Company Prescription drug costs are at an all-time high with no end in sight for both self-funded plan sponsors and the participants they represent. 79% of respondents in a recent Kaiser Family Foundation Health Tracking Poll felt that the cost of prescription drugs was unreasonable. To help offset the

Showing Self-Funded Plan Sponsors How Much We Care The month of February always inspires us to think about how much we at National CooperativeRx love our members — a group of several hundred self-funded plan sponsors. We hope our members already know they are at the core of everything our organization aims to accomplish, but

The number of unused medications in American households has significantly increased in recent years, resulting in excess waste. According to a recent study, approximately two out of three prescription medications were reported unused; common reasons include being weary of side effects, forgetfulness, and the patient’s disease or condition improving.1 If you fall into any of

Saying 2020 was an unusual year is an understatement. Experiencing a global pandemic was not something on our radar and hopefully it will soon be behind us. National CooperativeRx fared well despite working through pandemic-induced challenges familiar to many. Strong growth, financial strength and finding ways to add value for members all persevered in 2020

U.S. Supreme Court Ruling on ERISA The Employee Retirement Income Security Act of 1974 (ERISA) sets minimum standards for most private health plans and preempts states from enforcing coverage mandates on these plans. Since its passage, there have been many challenges to ERISA. The U.S. Supreme Court has consistently held firm on the power of

National CooperativeRx constantly monitors the pharmaceutical pipeline. As treatment options change, it’s important to know how those changes could impact your plan and which drugs bring the highest value. Our quarterly NCRx Pipeline Reports highlight some of the newest therapies coming to market and are not intended to imply formulary placement or coverage by CVS Caremark. Orladeyo®

In November, National CooperativeRx welcomed our third clinical intern Abby Weaver, for a six-week period. Abby is a fourth-year pharmacy student at the University of Wisconsin-Madison (UW-Madison), currently with us for one of her numerous rotations required to make her vision of becoming a licensed pharmacist a reality. Originally from St. Charles, Illinois, Abby received her undergraduate